Identification of irritable bowel syndrome in the Swedish National Patient Register: a validation study

References

• Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global study. Gastroenterology. 2021;160(1):99.e3–114.e3.
   Web of Science ®Google Scholar
• Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393.e5–1407.e5.
   Web of Science ®Google Scholar
• Simren M, Tornblom H, Palsson OS, et al. Management of the multiple symptoms of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2017;2(2):112–122.
   PubMed Web of Science ®Google Scholar
• Staller K, Olen O, Soderling J, et al. Mortality risk in irritable bowel syndrome: results from a nationwide prospective cohort study. Am J Gastroenterol. 2020;115(5):746–755.
   PubMed Web of Science ®Google Scholar
• Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119(3):654–660.
   PubMed Web of Science ®Google Scholar
• Frandemark A, Tornblom H, Jakobsson S, et al. Work productivity and activity impairment in irritable bowel syndrome (IBS): a multifaceted problem. Am J Gastroenterol. 2018;113(10):1540–1549.
   PubMed Web of Science ®Google Scholar
• Tornkvist NT, Aziz I, Whitehead WE, et al. Health care utilization of individuals with rome IV irritable bowel syndrome in the general population. UEG Journal. 2021;9(10):1178–1188.
   Google Scholar
• Flik CE, Laan W, Smout AJ, et al. Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands. BMC Gastroenterol. 2015;15:168.
   PubMed Web of Science ®Google Scholar
• Longstreth GF, Wilson A, Knight K, et al. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterology. 2003;98(3):600–607.
   PubMed Web of Science ®Google Scholar
• Flacco ME, Manzoli L, De Giorgio R, et al. Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis. Eur Rev Med Pharmacol Sci. 2019;23(7):2986–3000.
   PubMed Web of Science ®Google Scholar
• Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther. 2003;18(7):671–682.
   PubMed Web of Science ®Google Scholar
• Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40(9):1023–1034.
   PubMed Web of Science ®Google Scholar
• Tornblom H, Goosey R, Wiseman G, et al. Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: results from patient and healthcare professional surveys. United European Gastroenterol J. 2018;6(9):1417–1427.
   PubMed Web of Science ®Google Scholar
• Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712.e4–721.e4.
   Web of Science ®Google Scholar
• Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–917.
   PubMed Web of Science ®Google Scholar
• Kjellstrom L, Molinder H, Agreus L, et al. A randomly selected population sample undergoing colonoscopy: prevalence of the irritable bowel syndrome and the impact of selection factors. Eur J Gastroenterol Hepatol. 2014;26(3):268–275.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450.
   PubMed Web of Science ®Google Scholar
• Olen O, Stephansson O, Backman AS, et al. Pre- and perinatal stress and irritable bowel syndrome in young adults – A nationwide register-based cohort study. Neurogastroenterol Motil. 2018;30(11):e13436.
   PubMed Web of Science ®Google Scholar
• Zoller B, Ohlsson H, Waehrens R, et al. Association of irritable bowel syndrome and venous thromboembolism. Scand J Gastroenterol. 2018;53(7):784–789.
   PubMed Web of Science ®Google Scholar
• Waehrens R, Li X, Sundquist J, et al. Perinatal and familial risk factors for irritable bowel syndrome in a Swedish national cohort. Scand J Gastroenterol. 2018;53(5):559–566.
   PubMed Web of Science ®Google Scholar
• Waehrens R, Zoller B, Sundquist J, et al. A Swedish national adoption study of risk of irritable bowel syndrome (IBS). BMJ Open Gastroenterol. 2017;4(1):e000156.
   PubMedGoogle Scholar
• Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut. 1999;45(Suppl 2):II43–II47.
   PubMedGoogle Scholar
• Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–1491.
   PubMed Web of Science ®Google Scholar
• Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and rome IV. Gastroenterology. 2016;150(6):1262.e2–1279.e2.
   Web of Science ®Google Scholar
• Drossman DA, Janssens J, Talley NJ, et al. Identification of subgroups of functional bowel disorders. Gastroent Int. 1990;3:159–172.
   Google Scholar
• Benchimol EI, Manuel DG, To T, et al. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol. 2011;64(8):821–829.
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen. Kodningskvalitet i patientregistret – Ett nytt verktyg för att mäta kvalitet. Stockholm, Sweden: Socialstyrelsen; 2013.
   Google Scholar
• Swedish Association of Local Authorities and Regions SKoL. https://skr.se/skr.25.html
   Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991;100(2):350–358.
   PubMed Web of Science ®Google Scholar
• Jakobsson GL, Sternegard E, Olen O, et al. Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG). Scand J Gastroenterol. 2017;52(2):216–221.
   PubMed Web of Science ®Google Scholar
• Canavan C, West J, Card T. Calculating total health service utilisation and costs from routinely collected electronic health records using the example of patients with irritable bowel syndrome before and After their first gastroenterology appointment. Pharmacoeconomics. 2016;34(2):181–194.
   PubMed Web of Science ®Google Scholar
• Berkson J. Limitations of the application of fourfold table analysis to hospital data. Int J Epidemiol. 2014;43(2):511–515.
   PubMed Web of Science ®Google Scholar
• Lo B, Vind I, Vester-Andersen MK, et al. Validation of ulcerative colitis and crohn’s disease and their phenotypes in the danish national patient registry using a population-based cohort. Scand J Gastroenterol. 2020;55(10):1171–1175.
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Guttmann A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009;58(11):1490–1497.
   PubMed Web of Science ®Google Scholar
• Friedman MY, Leventer-Roberts M, Rosenblum J, et al. Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study. Clin Epidemiol. 2018;10:671–681.
   PubMed Web of Science ®Google Scholar
• Laugesen K, Ludvigsson JF, Schmidt M, et al. Nordic health registry-based research: a review of health care systems and key registries. Clin Epidemiol. 2021;13:533–554.
   PubMed Web of Science ®Google Scholar